Dental Implants in Turkey with Blood Thinners: What Must Be Checked Before Treatment?

Many people considering dental implants in Turkey take a medicine commonly described as a blood thinner. This may be an anticoagulant, such as warfarin or a direct oral anticoagulant (DOAC), or an antiplatelet medicine such as aspirin or clopidogrel.

In Short

• Blood thinners do not automatically rule out dental implant treatment, but suitability and planning require individual clinical assessment.
• Do not stop or change warfarin, a DOAC, aspirin, clopidogrel or another prescribed antithrombotic medicine without an individualized plan from the prescribing clinician.
• The dental team should confirm the exact medicine, indication, dose schedule, bleeding and clotting history, relevant medical conditions, and the extent of planned surgery.
• For warfarin, a recent INR may be needed; INR does not measure the effect of DOACs.

These medicines can affect bleeding, but they do not automatically mean that implant treatment is unsuitable. The dental and medical teams must understand exactly which medicine you take, why you take it, how stable your condition is, and how extensive the planned implant treatment will be. A straightforward implant placement is not the same as multiple implants combined with extractions, bone augmentation or a sinus-lift procedure.

At Estexper Clinic, patients travelling to Turkey should provide complete medical information before booking treatment. The final decision about suitability and any medication plan must be made by qualified dental and medical professionals, including the clinician who prescribed your antithrombotic medicine when necessary.

Can you have dental implants while taking blood thinners?

In many cases, dental implant treatment can be considered while a patient is taking anticoagulant or antiplatelet medication. Implant-specific research has generally reported low absolute bleeding rates, and some reviews have not found a clear need to routinely stop antithrombotic therapy when appropriate local haemostatic measures are used.

However, the evidence is limited and not completely consistent. More recent research has reported an association between antithrombotic therapy and increased postoperative bleeding after implant surgery. This does not mean that treatment is unsuitable for everyone, but it supports individual assessment, especially when surgery is extensive or the patient takes more than one antithrombotic medicine.

Stopping medication without medical advice can be dangerous. Depending on the reason for treatment, interruption may increase the risk of a blood clot, stroke, heart attack or stent thrombosis. Patients should never stop warfarin, a DOAC, aspirin, clopidogrel or another prescribed antithrombotic medicine independently.

What must be checked before implant treatment?

1. The exact medication and dose

The clinic needs an accurate list of every medicine you take. This should include the generic or brand name, strength, dose, dosing schedule and the time of day it is taken. Bring the original packaging or a current medication list if you travel to Turkey.

Important examples include:

• Warfarin and other vitamin K antagonists
• DOACs such as apixaban, dabigatran, edoxaban or rivaroxaban
• Aspirin and other antiplatelet medicines
• Clopidogrel or dual antiplatelet therapy
• Injectable anticoagulants
• Combinations of anticoagulants and antiplatelet medicines

The prescribing clinician and Turkish dental team must know whether the medicine is taken once or more than once daily and when the last dose was taken. Timing can be relevant to planning higher-bleeding-risk procedures, but any medication change must be individualized and agreed by the responsible clinicians.

2. Why the medicine was prescribed

The reason for antithrombotic treatment affects the risks of changing or interrupting it. Tell the clinic if the medicine was prescribed for atrial fibrillation, a previous clot, a mechanical heart valve, a recent heart event, a coronary stent, or another medical condition.

Also provide the name and contact details of the prescribing doctor or clinic. This is particularly important if the planned treatment involves several implants, extensive gum-flap surgery, extractions, bone augmentation or a sinus lift.

3. Duration and stability of treatment

The team should know when treatment began and whether the dose has changed recently. A newly started or frequently adjusted medicine may require closer communication with the prescriber than a stable long-term prescription.

Patients should also report any previous bleeding problems, such as prolonged bleeding after dental work, surgery or injury. Easy bruising, frequent nosebleeds or unexplained bleeding should be discussed before treatment.

4. Kidney, liver and blood conditions

Kidney and liver disease can affect how some medicines work and may influence bleeding risk. The team should also be told about thrombocytopenia, inherited bleeding disorders, cancer treatment or any other condition affecting blood clotting.

Provide recent medical reports when available. The need for blood tests depends on the medicine, the planned procedure and your medical history. A qualified clinician should decide which tests are appropriate.

5. Other medicines and supplements

Some medicines can increase bleeding risk when combined with anticoagulants or antiplatelet drugs. Give the clinic a complete list, including prescription medicines, over-the-counter products, vitamins and herbal supplements. Do not assume that a non-prescription product is irrelevant.

Which blood tests may be needed?

Warfarin and the INR test

For patients taking warfarin or another vitamin K antagonist, an INR measurement is commonly used to assess the effect of treatment. Dental guidance recommends checking the INR ideally within 24 hours before treatment likely to cause bleeding, or within 72 hours when the INR is stable.

Dental treatment can generally proceed without interrupting warfarin when the INR is below 4, according to the supplied clinical guidance. If the INR is 4 or higher, invasive treatment should generally be delayed or referred for further assessment. The treating clinician must interpret the result in the context of the planned surgery and the patient’s overall health.

DOACs and INR

The INR test used for warfarin is not a suitable way to measure the anticoagulant effect of DOACs such as apixaban, dabigatran, edoxaban or rivaroxaban. Patients taking a DOAC should not assume that a normal or available INR result confirms that the medicine has no effect.

For lower-bleeding-risk dental procedures, guidance generally advises continuing DOAC therapy. For higher-risk procedures, a specific dose-timing strategy may be considered, but the evidence is of very low certainty. Any plan must be individualized by the treating dental team and the prescribing clinician; patients should not alter doses themselves.

Antiplatelet medicines

Aspirin, clopidogrel and dual antiplatelet therapy are usually not altered for dental procedures. Bleeding is often managed with local measures rather than by stopping treatment. Extra consultation is important for patients with a coronary stent, combined antithrombotic therapy or other bleeding-risk conditions.

Does the extent of implant surgery change the decision?

Yes. The planned procedure should be classified before a decision is made. A single, straightforward implant may involve a different bleeding risk from several implants placed during a longer operation.

The assessment should specifically consider whether treatment includes:

• One or several implant placements
• Tooth extractions during the same visit
• Extensive flap surgery
• Bone augmentation or grafting
• Sinus-lift surgery
• Other procedures expected to create a larger wound

Extensive treatment requires careful case selection and a documented plan between the prescribing clinician and the Turkish dental team. For international patients, this communication should take place before travel rather than being arranged only after arrival.

How should international patients prepare for treatment in Turkey?

Send complete records before travelling

Before your appointment, share your medication list, medical history, relevant test results and details of your prescribing doctor. Include information about previous bleeding or clotting problems and any recent changes to your medicines.

If your treatment plan may involve grafting, a sinus lift, extractions or multiple implants, ask the clinic whether additional medical clearance is required. The treatment plan should be based on your individual condition, not only on a remote questionnaire.

Agree on medication instructions in writing

Do not rely on informal advice to stop or delay your medication. If dose timing or interruption is considered, the instruction should be individualized and clearly documented by the appropriate clinician. The plan should identify which medicine is involved, what action is advised and when normal dosing should continue.

Patients should also understand which clinician to contact if bleeding occurs after returning home. This is especially important when treatment takes place abroad and the patient’s regular doctor is in another country.

Allow time for communication

Medical correspondence may need to be exchanged between the clinic in Turkey and your local prescriber. Avoid arranging complex treatment at very short notice if there is not enough time to review your medication and medical history safely.

How is bleeding managed during and after implant placement?

Local haemostasis is central to dental treatment for patients taking antithrombotic medicines. Depending on the procedure, the dental team may use firm pressure, suturing, packing and haemostatic agents to control bleeding. The specific measures depend on the surgical site and the extent of treatment.

Patients should follow the clinic’s written aftercare instructions carefully. Do not disturb the treated area unnecessarily, and contact the dental team if bleeding does not settle as instructed or appears to be increasing. If you experience severe or persistent bleeding, seek urgent medical or dental assistance.

Before leaving Turkey, ask for written information about the procedure, prescribed or recommended medicines, emergency contact details and follow-up arrangements. Make sure you know whether your local dentist or doctor should review the surgical site after you return home.

What are the main risks?

The principal concern related to blood thinners is bleeding during or after surgery. The risk may be greater with extensive procedures, multiple implants, combined antithrombotic therapy, impaired kidney or liver function, low platelet counts or other bleeding conditions.

At the same time, changing antithrombotic treatment can create a clotting risk. This is why the safest approach is usually not to focus on bleeding alone. The clinical team must balance bleeding risk against the reason for anticoagulant or antiplatelet therapy.

Implant-specific evidence remains limited, with studies differing in design and patient groups. Some systematic reviews report no statistically significant increase in bleeding compared with untreated patients, while newer evidence suggests that postoperative bleeding may be more likely in patients receiving antithrombotic therapy. Your own risk cannot be calculated from a general statistic or online article.

When might treatment need to be postponed or reconsidered?

Implant treatment may need to be delayed while the team obtains further information, repeats an appropriate test or consults the prescribing clinician. Examples include an INR of 4 or higher in a patient taking warfarin, unclear medication instructions, an unstable medical condition, unexplained bleeding, or a planned procedure that is more extensive than initially expected.

This is not necessarily a permanent refusal of treatment. It may be a safety step to clarify the diagnosis, coordinate care or modify the treatment plan. In some cases, a less extensive staged approach may be considered, but only after assessment by qualified clinicians.

Frequently asked questions

Should I stop my blood thinner before travelling to Turkey?

No. Do not stop or change an anticoagulant or antiplatelet medicine without an individualized instruction from the prescribing clinician. Bring enough medicine for the journey and keep it in its original packaging.

Is an INR test needed for every patient?

No. INR testing is relevant to warfarin and other vitamin K antagonists, not as a general test for DOAC activity. The need for testing depends on the medication, medical history and planned procedure.

Can I have several implants on blood thinners?

It may be possible, but several implants may represent a more extensive procedure than a straightforward single implant. The plan should account for surgery size, other procedures, medical conditions and the specific antithrombotic regimen.

Can the Turkish clinic contact my doctor?

Yes, and this may be important when treatment is extensive or your medication plan is complex. Give permission for the relevant medical information to be shared and provide accurate contact details before travelling.

Key points for patients

• Blood thinners do not automatically exclude dental implant treatment.
• Never stop warfarin, DOACs, aspirin, clopidogrel or another prescribed medicine independently.
• Provide the exact medicine, dose, schedule, indication and prescriber’s details.
• Warfarin treatment generally requires a recent INR assessment; an INR below 4 is commonly used for proceeding according to dental guidance.
• INR does not measure the effect of DOACs reliably.
• Extensive implant surgery requires more careful planning than straightforward implant placement.
• Local haemostatic measures are an important part of bleeding management.
• International patients should arrange communication between their prescriber and the Turkish dental team before travelling.

At Estexper Clinic, patients taking blood thinners should provide their complete medical information during the consultation process. A qualified clinician can then assess whether implant treatment is appropriate, whether further medical input is needed and how the procedure should be planned safely.

Medical References

1. Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs — Scottish Dental Clinical Effectiveness Programme (SDCEP), NHS Education for Scotland; NICE-accredited guidance.
2. Oral Anticoagulant and Antiplatelet Medications and Dental Procedures — American Dental Association.
3. Risk of bleeding with dental implant surgery in patients on anticoagulant or antiplatelet drugs: a systematic review and meta-analysis — Acta Odontologica Scandinavica; indexed in PubMed.
4. Risk of Bleeding during Implant Surgery in Patients Taking Antithrombotics: A Systematic Review — International Journal of Oral & Maxillofacial Implants; indexed in PubMed.
5. Postoperative Bleeding Complications Associated With Dental Implant Placement in Patients Receiving Antithrombotic Therapy: A Systematic Review and Meta-Analysis — Peer-reviewed systematic review in PubMed Central.